Alloplex Biotherapeutics
Cambridge, MA
Alloplex Biotherapeutics is dedicated to exploring the higher order combinatorial space of immunomodulators to develop an effective anti-tumor vaccine. This approach is applicable to all tumor types and is particularly suited to combinations with checkpoint inhibitors. Alloplex is a private company and currently supported by angel investment
alloplexbio.comCompany Details
Founded
- 2016
Employees
- Between 5 - 10 employees
Raised
- $21,200,000
Headquarters Location
- Cambridge, MA
Public
- No
Acquired
- No
CEO
Frank Borriello
Founders
- Frank Borriello
Company Collections
These are collections Alloplex Biotherapeutics is a part of. Click on the collection name to view similar companies.